PURPOSE: The response to the COVID-19 pandemic has affected the management of patients with cancer. In this pooled retrospective analysis, we describe changes in management patterns for patients with cancer diagnosed with COVID-19 in two academic institutions in the San Francisco Bay Area. MATERIALS AND METHODS: Adult and pediatric patients diagnosed with COVID-19 with a current or historical diagnosis of malignancy were identified from the electronic medical record at the University of California, San Francisco, and Stanford University. The proportion of patients undergoing active cancer management whose care was affected was quantified and analyzed for significant differences with regard to management type, treatment intent, and the time of COVID-19 diagnosis. The duration and characteristics of such changes were compared across subgroups. RESULTS: A total of 131 patients were included, of whom 55 were undergoing active cancer management. Of these, 35 of 55 (64%) had significant changes in management that consisted primarily of delays. An additional three patients not undergoing active cancer management experienced a delay in management after being diagnosed with COVID-19. The decision to change management was correlated with the time of COVID-19 diagnosis, with more delays identified in patients treated with palliative intent earlier in the course of the pandemic (March/April 2020) compared with later (May/June 2020) (OR, 4.2; 95% CI, 1.03 to 17.3; P = .0497). This difference was not seen among patients treated with curative intent during the same timeframe. CONCLUSION: We found significant changes in the management of cancer patients with COVID-19 treated with curative and palliative intent that evolved over time. Future studies are needed to determine the impact of changes in management and treatment on cancer outcomes for patients with cancer and COVID-19.
PURPOSE: The response to the COVID-19 pandemic has affected the management of patients with cancer. In this pooled retrospective analysis, we describe changes in management patterns for patients with cancer diagnosed with COVID-19 in two academic institutions in the San Francisco Bay Area. MATERIALS AND METHODS: Adult and pediatric patients diagnosed with COVID-19 with a current or historical diagnosis of malignancy were identified from the electronic medical record at the University of California, San Francisco, and Stanford University. The proportion of patients undergoing active cancer management whose care was affected was quantified and analyzed for significant differences with regard to management type, treatment intent, and the time of COVID-19 diagnosis. The duration and characteristics of such changes were compared across subgroups. RESULTS: A total of 131 patients were included, of whom 55 were undergoing active cancer management. Of these, 35 of 55 (64%) had significant changes in management that consisted primarily of delays. An additional three patients not undergoing active cancer management experienced a delay in management after being diagnosed with COVID-19. The decision to change management was correlated with the time of COVID-19 diagnosis, with more delays identified in patients treated with palliative intent earlier in the course of the pandemic (March/April 2020) compared with later (May/June 2020) (OR, 4.2; 95% CI, 1.03 to 17.3; P = .0497). This difference was not seen among patients treated with curative intent during the same timeframe. CONCLUSION: We found significant changes in the management of cancer patients with COVID-19 treated with curative and palliative intent that evolved over time. Future studies are needed to determine the impact of changes in management and treatment on cancer outcomes for patients with cancer and COVID-19.
Authors: Andrés Coca-Pelaz; Robert P Takes; Kate Hutcheson; Nabil F Saba; Missak Haigentz; Carol R Bradford; Remco de Bree; Primož Strojan; Valerie J Lund; William M Mendenhall; Iain J Nixon; Miquel Quer; Alessandra Rinaldo; Alfio Ferlito Journal: Adv Ther Date: 2018-02-02 Impact factor: 3.845
Authors: David M Waterhouse; R Donald Harvey; Patricia Hurley; Laura A Levit; Edward S Kim; Heidi D Klepin; Kathryn Finch Mileham; Grzegorz Nowakowski; Caroline Schenkel; Courtney Davis; Suanna S Bruinooge; Richard L Schilsky Journal: JCO Oncol Pract Date: 2020-05-12
Authors: Lennard Yw Lee; Jean-Baptiste Cazier; Vasileios Angelis; Roland Arnold; Vartika Bisht; Naomi A Campton; Julia Chackathayil; Vinton Wt Cheng; Helen M Curley; Matthew W Fittall; Luke Freeman-Mills; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin Jx Lee; Rebecca J Lee; Sophie E McGrath; Christopher P Middleton; Nirupa Murugaesu; Thomas Newsom-Davis; Alicia Fc Okines; Anna C Olsson-Brown; Claire Palles; Yi Pan; Ruth Pettengell; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Thomas Starkey; Chris D Turnbull; Csilla Várnai; Nadia Yousaf; Rachel Kerr; Gary Middleton Journal: Lancet Date: 2020-05-28 Impact factor: 79.321
Authors: A Sud; M E Jones; J Broggio; C Loveday; B Torr; A Garrett; D L Nicol; S Jhanji; S A Boyce; F Gronthoud; P Ward; J M Handy; N Yousaf; J Larkin; Y-E Suh; S Scott; P D P Pharoah; C Swanton; C Abbosh; M Williams; G Lyratzopoulos; R Houlston; C Turnbull Journal: Ann Oncol Date: 2020-05-19 Impact factor: 32.976
Authors: Yüksel Ürün; Syed A Hussain; Ziad Bakouny; Daniel Castellano; Saadettin Kılıçkap; Gilberto Morgan; Rana R Mckay; Kevin Pels; Andrew Schmidt; Deborah B Doroshow; Fábio Schütz; Laurence Albiges; Gilberto Lopes; James W F Catto; Solange Peters; Toni K Choueiri Journal: JCO Glob Oncol Date: 2020-08
Authors: Donna R Rivera; Solange Peters; Yu Shyr; Gary H Lyman; Jeremy L Warner; Orestis A Panagiotou; Dimpy P Shah; Nicole M Kuderer; Chih-Yuan Hsu; Samuel M Rubinstein; Brendan J Lee; Toni K Choueiri; Gilberto de Lima Lopes; Petros Grivas; Corrie A Painter; Brian I Rini; Michael A Thompson; Jonathan Arcobello; Ziad Bakouny; Deborah B Doroshow; Pamela C Egan; Dimitrios Farmakiotis; Leslie A Fecher; Christopher R Friese; Matthew D Galsky; Sanjay Goel; Shilpa Gupta; Thorvardur R Halfdanarson; Balazs Halmos; Jessica E Hawley; Ali Raza Khaki; Christopher A Lemmon; Sanjay Mishra; Adam J Olszewski; Nathan A Pennell; Matthew M Puc; Sanjay G Revankar; Lidia Schapira; Andrew Schmidt; Gary K Schwartz; Sumit A Shah; Julie T Wu; Zhuoer Xie; Albert C Yeh; Huili Zhu Journal: Cancer Discov Date: 2020-07-22 Impact factor: 38.272
Authors: Christina M Theodorou; Alana L Beres; Michelle Nguyen; Shannon L Castle; Claire Faltermeier; Shant Shekherdimian; Christine Tung; Daniel A DeUgarte; Erin G Brown Journal: J Surg Res Date: 2021-06-17 Impact factor: 2.192